Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Glycoprotein / GP (Virus) (AA 33-637) protein (His tag)

Origine: Ebola Virus Hôte: HEK-293 Cells Recombinant >85 % as determined by SDS-PAGE.
N° du produit ABIN2870779
  • Antigène
    Glycoprotein / GP (Virus)
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 33-637
    Origine
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    Ebola Virus
    Source
    • 9
    HEK-293 Cells
    Purification/Conjugué
    His tag
    Séquence
    AA 33-637
    Attributs du produit
    Ebolavirus EBOV(subtype Zaire,strain Kikwit-95) GP, containing GP1 and GP2, is fused with a polyhistidine tag at the C-terminus, and has a calculated MW of 67 kDa. The predicted N-terminus is Ile 33. The reducing (R) protein migrates as 21-23 kDa (GP2-delta) and 110-120 kDa (GP1) in SDS-PAGE .
    Pureté
    >85 % as determined by SDS-PAGE.
    niveau d'endotoxine
    Less than 1.0 EU per μg by the LAL method.
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4
    Conseil sur la manipulation
    Please avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
  • Antigène
    Glycoprotein / GP (Virus)
    Classe de substances
    Viral Protein
    Sujet
    EBOV encodes seven structural proteins: nucleoprotein (NP), polymerase cofactor (VP35), (VP40), GP, transcription activator (VP30), VP24, and RNA polymerase (L). GP protein contains 160- kDa envelope-attached glycoprotein (GP) and a 110 kDa secreted glycoprotein (sGP). GP is a class I fusion protein which assembles as trimers on viral surface and plays an important role in virus entry and attachment. Mature GP is a disulfide-linked heterodimer formed by two subunits, GP1 and GP2, which are generated from the proteolytical process of GP precursor (pre-GP) by cellular furin during virus assembly . GP1 is responsible for binding to the receptor(s) on target cells. Interacts with CD209/DC-SIGN and CLEC4M/DC-SIGNR which act as cofactors for virus entry into the host cell. GP2 acts as a class I viral fusion protein. GP1,2 mediates endothelial cell activation and decreases endothelial barrier function. sGP seems to possess an anti-inflammatory activity as it can reverse the barrier-decreasing effects of TNF alpha.
    Poids moléculaire
    67.2 kDa
Vous êtes ici:
Support technique